4892 — Cyfuse Biomedical KK Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥6bn
- ¥3bn
- ¥61m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -327 | 145 | -472 | -586 |
Depreciation | ||||
Non-Cash Items | -47.2 | -81 | 45.5 | -119 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 47.8 | 79.1 | -31.4 | 105 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Taxes Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -294 | 162 | -404 | -562 |
Capital Expenditures | -0.264 | — | -228 | -19.5 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | — | -50.6 | -202 | — |
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -0.264 | -50.6 | -431 | -19.5 |
Financing Cash Flow Items | -0.001 | -0.001 | — | — |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 489 | 229 | 2,659 | 18.2 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 195 | 340 | 1,824 | -564 |